The Journal of Immunology, Vol 152, Issue 2 446-454, Copyright © 1994 by American Association of Immunologists

ARTICLES

Long term activation of natural killer cells results in modulation of beta 1-integrin expression and function

F Mainiero, A Gismondi, M Milella, S Morrone, G Palmieri, M Piccoli, L Frati and A Santoni
Department of Experimental Medicine, University of Rome, La Sapienza, Italy.

Integrin expression and function is largely modulated by cell activation. Here we provide evidence that long term activation of human NK cells results in a marked modulation of beta 1-integrin expression and adhesive functions. By flow cytometry and immunochemical analysis we have detected induction of alpha 1 beta 1 and alpha 2 beta 1, increased expression of alpha 4 beta 1 and alpha 5 beta 1, and decline of alpha 6 beta 1 on CD3-CD56+ NK cells generated from 10-day coculture of nonadherent PBMC with irradiated RPMI 8866 EBV+ lymphoblastoid B cell line. Adhesion assays performed on extracellular matrix-coated plates showed that, unlike fresh NK cells, long term-activated NK cells bind to native collagen I via alpha 2 beta 1 and to heat-denatured collagen I in an RGD-dependent manner, although they lose the ability to bind to laminin. In regard to the adhesion to FN, no major quantitative changes are observed after long term NK cell activation. However, whereas alpha 4 beta 1 and alpha 5 beta 1 completely mediate the adhesion of fresh NK cells to fibronectin, binding of activated NK cells is only partially beta 1-dependent and seems to involve also non- beta 1-integrin(s) recognizing and RGD sequence. The modulation of beta 1-integrin expression and the acquisition of new adhesive properties on long term-activated NK cells may be relevant for their traffic and tissue localization during inflammation and immune response.

This article has been cited by other articles:

				T. Igarashi, J. Wynberg, R. Srinivasan, B. Becknell, J. P. McCoy Jr, Y. Takahashi, D. A. Suffredini, W. M. Linehan, M. A. Caligiuri, and R. W. Childs Enhanced cytotoxicity of allogeneic NK cells with killer immunoglobulin-like receptor ligand incompatibility against melanoma and renal cell carcinoma cells Blood, July 1, 2004; 104(1): 170 - 177. [Abstract] [Full Text] [PDF]

				H. Arase, T. Saito, J. H. Phillips, and L. L. Lanier Cutting Edge: The Mouse NK Cell-Associated Antigen Recognized by DX5 Moncoclonal Antibody is CD49b ({alpha}2 Integrin, Very Late Antigen-2) J. Immunol., August 1, 2001; 167(3): 1141 - 1144. [Abstract] [Full Text] [PDF]

				M. Milella, A. Gismondi, P. Roncaioli, G. Palmieri, S. Morrone, M. Piccoli, L. Frati, M. G. Cifone, and A. Santoni {beta}1 Integrin Cross-Linking Inhibits CD16-Induced Phospholipase D and Secretory Phospholipase A2 Activity and Granule Exocytosis in Human NK cells: Role of Phospholipase D in CD16-Triggered Degranulation J. Immunol., February 15, 1999; 162(4): 2064 - 2072. [Abstract] [Full Text] [PDF]

				F. Mainiero, A. Gismondi, A. Soriani, M. Cippitelli, G. Palmieri, J. Jacobelli, M. Piccoli, L. Frati, and A. Santoni Integrin-mediated Ras-Extracellular Regulated Kinase (ERK) Signaling Regulates Interferon gamma  Production in Human Natural Killer Cells J. Exp. Med., October 5, 1998; 188(7): 1267 - 1275. [Abstract] [Full Text] [PDF]

				M. P. Miles, S. K. Leach, W. J. Kraemer, K. Dohi, J. A. Bush, and A. M. Mastro Leukocyte adhesion molecule expression during intense resistance exercise J Appl Physiol, May 1, 1998; 84(5): 1604 - 1609. [Abstract] [Full Text] [PDF]

				C. A. Power, D. J. Church, A. Meyer, S. Alouani, A. E.I. Proudfoot, I. Clark-Lewis, S. Sozzani, A. Mantovani, and T. N.C. Wells Cloning and Characterization of a Specific Receptor for the Novel CC Chemokine MIP-3alpha from Lung Dendritic Cells J. Exp. Med., September 15, 1997; 186(6): 825 - 835. [Abstract] [Full Text] [PDF]